Blog

Diabetic Retinopathy: Why Early Detection Matters

April 16, 2025

Diabetic Retinopathy: Why Early Detection Matters

Diabetes is a chronic disease that affects millions of people worldwide, characterized by elevated blood glucose levels resulting from the body’s inability to effectively produce or use insulin. These elevated blood sugar levels can lead to numerous health complications that ultimately stem from those affected blood vessels within the body.

Perhaps the most significant vision-threatening complication that often goes unnoticed until it reaches an advanced stage is diabetic retinopathy. Diabetic retinopathy is a condition that results from damaged blood vessels within the retina, which serves as the light-sensitive tissue located at the back of the eye. Unmanaged cases can progress from mild vision disturbances in the earliest stages to complete blindness among late-stage diagnoses.

As one of the leading causes of vision impairment and blindness among working-age adults, the need for increased access to care and proactive promotion of annual eye exams remains critical. Our team at Retina Labs dives into the prevalence, risks, screening methods, and frequently asked questions about this diabetic eye disease and why early detection is crucial to preserving sight for diabetics.

The Prevalence of Diabetic Retinopathy Today

According to the CDC, approximately one in four adults diagnosed with diabetes develop some form of diabetic retinopathy. Within that cohort, roughly 5% suffer from vision-threatening stages of the disease, also known as proliferative diabetic retinopathy. While current screening rates remain suboptimal, with nearly one-third of adult diabetics in the U.S. forgoing their recommended annual eye exams, these numbers are projected to increase significantly in the coming years ahead.

Key Increased Risk Factors

While anyone with diabetes can develop diabetic retinopathy, there are several prominent risk factors that increase the likelihood of occurrence:

  • Duration: Simply put, the longer you've had diabetes, the greater the risk.
  • Poor Blood Sugar Control: Since chronic hyperglycemia accelerates blood vessel damage, maintaining a controlled blood sugar level near normal can reduce the risk of developing diabetic retinopathy by nearly 50%.
  • High Blood Pressure & Cholesterol: Studies have shown that each percentage point reduction in HbA1c levels significantly lowers the risk of developing or worsening diabetic retinopathy.
  • Smoking: Tobacco use increases inflammation and the likelihood of vascular damage.

Since diabetic retinopathy can often develop without any noticeable symptoms in its early stages, diabetic patients need to remain proactive in completing their eye exams annually. Should diabetics wait to complete their routine screening recommendations until any visible symptoms become apparent, their condition and progression of diabetic retinopathy may already be at an advanced stage beyond effective treatment planning.

Routine Screening: Your Best Defense Against Vision Loss

The National Eye Institute (NEI) emphasizes that early detection, timely treatment, and appropriate follow-up care can reduce the risk of severe vision loss by up to 95%.

Recommended Screening Guidelines:

  • Type 1 Diabetes: Begin eye screening annually within 5 years of diagnosis.
    • 25% of individuals with a Type 1 Diabetes diagnosis of at least 5 years will develop some form of diabetic retinopathy.
    • 60% of individuals with a Type 1 Diabetes diagnosis for more than 10 years will develop some form of diabetic retinopathy.
  • Type 2 Diabetes: Complete a comprehensive dilated eye exam at time of diagnosis. Annual diabetic eye exams to be completed thereafter.
  • Prenatal Diabetics: Complete an eye exam within early stages of pregnancy with the potential for additional follow-up visits as needed.

Common Screening Methods for Diabetic Retinopathy

There are several technologies and methods used to screen for diabetic retinopathy:

Dilated Eye Exams: Considered the gold standard and most traditional method commonly used, an ophthalmologist or optometrist will dilate the pupils using eye drops to examine the retina and optic nerve for signs of damage, such as microaneurysms, hemorrhages, or neovascularization.

Fundus Photography: Eliminating the need for more invasive screening procedures that require dilation, high-resolution images of the retina are captured using a non-mydriatic fundus camera before being analyzed by licensed ophthalmologists.

Optical Coherence Tomography (OCT): OCT uses light waves to capture cross-sectional images of the retina. These detailed tissue images help detect any swelling or fluid accumulation, though these signs are typically seen as key markers of diabetic macular edema (DME).

Fluorescein Angiography: This specialized yet highly invasive procedure is typically used for diagnosis and treatment planning rather than routine screening. It requires injecting dye into the bloodstream to help highlight blood vessels within the retina for greater clinical evaluation purposes.

Frequently Asked Questions (FAQs)

Q: Is the screening process painful or invasive?
A: Most modern screening methods, particularly those using non-mydriatic fundus cameras for retinal imaging, are painless and non-invasive.

Q: How long does a diabetic eye exam take?
A: The entire process typically takes 30 minutes or less, depending on the screening methods being used.

Q: Can the effects of diabetic retinopathy be reversed?
A: While early-stage complications can improve in combination with better control measures for managing diabetes, advanced stages may require more intensive treatment options, such as laser therapy, anti-VEGF injections, or vitrectomy surgery.

Q: What common symptoms should I watch for?
A: Blurry, distorted, double, and/or fluctuating vision, eye floaters and spots, or corneal abnormalities are common symptoms reported by patients. However, due to the nature of diabetic retinopathy often being asymptomatic in terms of silent disease progression, routine eye exams are essential to identifying concerns before any visible issues occur.

How We Help Improve Diabetic Retinopathy Screening Rates & Health Outcomes

Retina Labs in-home preventive screenings for diabetic retinopathy enable health plans to close more HEDIS gaps in care and improve Star Ratings, all while lowering healthcare costs through better disease detection and care management.

Our highly trained Retinal Imaging Technologists use a portable non-mydriatic fundus camera to capture high-resolution images in anon-invasive manner, creating a relaxed environment for health plan members to complete this process within the comfort of their own homes. With industry-leading image quality, the retinal images captured by our team are analyzed and interpreted by board-certified retina specialist ophthalmologists. Each member's retinal images are carefully examined by these retina specialists to determine if their results reveal any sight-threatening concerns.

In cases where our retina specialist ophthalmologists confirm the presence of sight-threatening diabetic eye disease, Retina Labs provides critical value alert outreach to notify health plan members. This approach ensures that each member with abnormal screening results understands their diagnosis while encouraging them to seek appropriate follow-up care with an eye care specialist or their PCP.

All diabetic eye exam screening results are delivered directly to each member along with their PCP using secure electronic messaging that also integrates with the provider's EMR system. The accompanying eye exam reports are easy to understand while providing actionable insights for care plan recommendations relative to the full staging of pathology for diabetic retinopathy severity.

By meeting your members where they are most comfortable and familiar with, we remove one of the greatest barriers to delivering preventive care - enabling health plans to improve adherence rates, member satisfaction, and quality scores.

Contact us today to learn more about our comprehensive approach to providing in-home diabetic eye exams directly to your health plan members – all within the comfort of their own homes.

Sources:

Blog

Diabetic Retinopathy: Why Early Detection Matters

Our team at Retina Labs dives into the prevalence, risks, screening methods, and frequently asked questions about this diabetic eye disease and why early detection is crucial to preserving sight for diabetics.

Read More
April 16, 2025
Employee Spotlight

Meet Seth Graham: Providing Quality In-Home Preventive Care Screenings Directly to Health Plan Members Nationwide

Meet Seth Graham, one of our remarkable Field Technologists who brings Retina Labs preventive healthcare screening programs straight to the doorsteps of those individuals who need it most.

Read More
April 2, 2025
Blog

How At-Home Lab Testing is Making Preventive Care More Accessible

By making preventive care more member-centric and accessible, at-home lab testing is poised to play a pivotal role in reducing the burden of chronic disease progression while improving population health overall.

Read More
March 11, 2025
Health

Retina Labs Direct-to-Patient At-Home Lab Testing Programs Help Health Plans Boost Star Ratings

As the demand for accessible and convenient at-home healthcare options continues to rise, Retina Labs has positioned itself as a trusted partner for health plans navigating the ever-evolving landscape of home-based care.

Read More
February 5, 2025
Health

Retina Labs Achieves Record Growth by Elevating In-Home Access to Care Industry Standards

By combining in-home preventive care programs with at-home diagnostic testing services, Retina Labs is on a mission to deliver seamless member-centric experiences that improve health outcomes.

Read More
February 19, 2025
Events

Retina Labs Sponsors the SSN 10th Annual Medicare Star Ratings & Quality Improvement Summit Conference in New Orleans

Retina Labs will be sponsoring and exhibiting at the upcoming SSN 10th Annual Medicare Star Ratings & Quality Improvement Summit in New Orleans from December 3rd - December 5th, 2024.

Read More
November 7, 2024
Events

Retina Labs Sponsors 14th Annual HEDIS® & Quality Improvement Summit

Retina Labs will be sponsoring and exhibiting at the upcoming 14th Annual HEDIS® & Quality Improvement Summit in Las Vegas.

Read More
September 2, 2024
Events

RETINA LABS SPONSORS 2023 QUALIPALOOZA CONFERENCE

Retina Labs will be sponsoring and exhibiting at the upcoming Qualipalooza conference in Miami, June 20-23, 2023.

Read More
May 1, 2023
Events

Retina Labs Sponsors 9th Annual Medicare Star Ratings & Quality Assurance Summit

Retina Labs will be sponsoring and exhibiting at the upcoming 9th Annual Medicare Star Ratings & Quality Assurance Summit in Orlando, December December 6-8, 2023.

Read More
October 3, 2023
Events

RETINA LABS TO SPONSOR & EXHIBIT AT AHIP 2019

Retina Labs is pleased to announce that it will sponsor exhibit at the upcoming America’s Health Insurance Plans (AHIP) Institute and Expo to be held in Nashville, TN June 19th to 21st, 2019. Known as the Essential Event for the Health Care Industry, AHIP’s Institute & Expo consistently delivers results for hundreds of solutions providers.

Read More
May 14, 2019
Events

RETINA LABS SPONSORS 2023 RISE NATIONAL CONFERENCE

Retina Labs will be sponsoring and exhibiting at the upcoming Rise National conference in Colorado Springs, March 6-8, 2023.

Read More
February 1, 2023
Events

RETINA LABS SPONSORS 2022 RISE STAR RATINGS MASTER CLASS CONFERENCE

Retina Labs will be sponsoring and exhibiting at the upcoming Rise STAR RATINGS MASTER CLASS conference in San Diego, December 13-15, 2022.

Read More
November 6, 2022
Events

Retina Labs Sponsors 2024 RISE National Conference

Retina Labs will be sponsoring and exhibiting at the upcoming Rise National conference in Nashville, March 17-19, 2024.

Read More
January 2, 2024
Medicine

RETINA LABS SELECTED FOR ONTARIO PROVINCIAL TELEOPHTHALMOLOGY PROGRAM

Retina Labs is pleased to announce that it has been selected by the Ontario Telemedicine Network (OTN) as the solution for its provincial Teleophthalmology Program.

Read More
February 8, 2017
Health

RICHARD PRIDHAM JOINS TELEHEALTH SOLUTIONS PROVIDER RETINA LABS

Retina Labs, a market innovator in teleophthalmology and virtual eye care solutions, has brought on Richard Pridham as its President and CEO and as an investor in the company.

Read More
June 3, 2016
Technology

THE FIRST NATIONS OF QUEBEC AND LABRADOR PARTNERS WITH RETINA LABS FOR DIABETIC RETINOPATHY SCREENING PROGRAM

The First Nations of Quebec and Labrador Health and Social Services Commission have partnered with Retina Labs to provide screening for diabetic retinopathy.

Read More
September 16, 2009
Health

RUIS MCGILL CHOOSES RETINA LABS FOR TELEOPHTHALMOLOGY PROGRAM

The McGill Integrated University Health Network or Réseau Universitaire Intégré de Santé (known as “RUIS”), has chosen Retina Labs iVision Solution for its teleophthalmology program.

Read More
November 20, 2013
Technology

MAISONNEUVE ROSEMOUNT HOSPITAL SELECTS RETINA LABS IVISION PLATFORM FOR DIABETIC RETINOPATHY SCREENING PROGRAM

Maisonneuve Rosemont, one of Montreal’s largest hospitals centres, has chosen iVision®, Retina Labs industry leading teleophthalmology and virtual care platform.

Read More
December 1, 2015
Technology

SAVING PATIENTS’ SIGHT REMOTELY

Dr. Marie Carole Boucher had had enough. Enough of seeing patients lose their sight because of a disease that was easily curable.

Read More
February 7, 2017
Technology

Retina Labs + Secure Exchange: Delivering Secure, Electronic Test Results to Providers

SES Notify Fast-Tracks Delivery of Retina Labs’ Diabetic Retinopathy Diagnosis to Close Care Gaps and Reduce the $500M in Healthcare Spend

Read More
March 8, 2024
Health

ONE VISION FOR TELEMEDICINE’S FUTURE

Diabetic retinopathy is on the rise in Ontario. It is estimated that there are 1.2 million people with diabetes in Ontario, with 20% of those expected to experience vision loss.

Read More
May 15, 2017
Health

NOVEMBER IS DIABETIC EYE DISEASE AWARENESS MONTH

November is officially Diabetic Eye Disease Awareness Month. Diabetic eye disease represents a group of eye conditions that affects those with diabetes.

Read More
November 1, 2017
Health

RETINA LABS RECOGNIZED AS INNOVATOR AND DISRUPTOR IN EYE HEALTHCARE

Retina Labs is excited to be one of a select group of companies mentioned in this report. Appearing in the category of Telemedicine / Telerefraction, Retina Labs has emerged a leader in the area of ocular telehealth.

Read More
October 15, 2018
Technology

RETINA LABS LAUNCHES COMPLYHUB

End-to-end solution enables health plans to improve Star ratings though better member compliance on diabetic eye exams and other preventive screenings.

Read More
October 28, 2020
Technology

RETINA LABS LAUNCHES PIONEERING TELECONSULTATION PLATFORM TO OFFER VIRTUAL EYE CARE DURING COVID-19 CRISIS

In response to the COVID-19 pandemic, Retina Labs has announced its latest in teleophthalmology innovation with the introduction of a telemedicine-based e-consultation platform specially designed for eye health.

Read More
April 13, 2020
Technology

RETINA LABS EXPANDS IN-HOME PREVENTIVE SCREENING SERVICE TO BETTER SERVICE HEALTH PLANS ACROSS THE U.S.

End-to-end solution enables health plans to improve Star ratings though better member compliance on diabetic eye exams and other preventive screenings.

Read More
April 7, 2021
Health

RETINA LABS RELEASES CASE STUDY ON SENTARA IN-HOME DIABETIC EYE EXAM PROGRAM

In-home program offers Sentara members convenient access to a range of screenings including diabetic eye exams, HbA1c, kidney health assessments, colon cancer testing, and bone mineral density scans.

Read More
May 6, 2024
chevron-left
chevron-right

Office Locations

Beautiful landscape picture of Nashville
Mon - Fri: 9am-5pm CST

Head Office

555 Marriott Drive, Suite 315, Nashville, TN 37214

Sales & Corporate Inquiries: (866) 344-2692
Fax: (866) 214-0724

Beautiful landscape picture of Montreal
Mon - Fri: 9am-5pm EST

Canadian Office

6500 Trans-Canada Hwy, Suite 400, Pointe Claire, QC, H9R 0A5

Phone: (514) 344-2692
Fax: (866) 214-0724